Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.

CONCLUSION: Erlotinib-associated GT was identified in 15% patients with NSCLC. Fluid-filled colon and segmental involvement were the most common imaging manifestations.
PMID: 32892106 [PubMed - indexed for MEDLINE]

Source: Clinical Lung Cancer - November 26, 2020 Category: Cancer & Oncology Authors: Pfau D, Guler E, Smith DA, Matsunaga F, Kikano EG, Tirumani SH, Dowlati A, Ramaiya NH Tags: Clin Imaging Source Type: research